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With the publication of the first articles of this 2012
volume, the Journal of Neurodevelopmental Disorders
enters the exciting world of open access publishing. The
Journal will now be published by BioMed Central, (part
of Springer Science+Business Media) as a fully open
access journal. This change will mean that all articles
will be made freely and permanently accessible online
immediately upon publication, will be available to read-
ers throughout the world without subscription charges
or registration barriers, and be indexed in both PubMed
and PubMed Central.
In line with BioMed Central’s copyright and license
policy, authors will retain the copyright to their work
and grant anyone the right to reproduce and dissemi-
nate their articles, as long as the integrity of the original
work is maintained and it is correctly cited (http://www.
biomedcentral.com/about/copyright). Authors submit-
ting from BioMed Central Member institutions have
article processing charges covered in full or in part by
their institutions (http://www.biomedcentral.com/
libraries/membership) and authors from countries in
low or low-middle income categories (as defined by the
World Bank) may have charges waived (http://www.bio-
medcentral.com/authors/oawaiverfund). Other waivers
may be available on a case by case basis.
Given the high relevance of the work published in this
journal to families, clinicians and researchers throughout
the world, we are committed to this new and equitable
approach to dissemination of scientific findings in our
field.
The Journal provides a unique forum for the integra-
tion of knowledge across a number of neurodevelop-
mental disorders, underlying pathogenetic mechanisms,
and scientific disciplines relevant to understanding the
pathogenesis of neurodevelopmental disorders.
In the Foreward to the inaugural issue of the Journal,
Tom Insel, Director of the National Institutes of Mental
Health, wrote “There has never been a better time for
this integration and never a greater need” [1]. The most
recent issue (vol 3, issue 4) [2] included papers on
Turner Syndrome, Autism Spectrum Disorder, Prader-
Willi Syndrome, William’s Syndrome, Fragile X, Specific
Language Impairment and Stuttering, and covered a
wide-range of cross-cutting perspectives from the effects
of prenatal exposures on risk for autism to the impact
of sex differences on the developing brain. In this same
issue, the Special Section entitled ‘Building an Epige-
netics Perspective on Language, Speech and Reading
Impairments’, edited by Mabel Rice [3], examined in
more detail genetic mechanisms underlying disorders of
communication. Clearly this new Journal has met the
challenge of integrating across multiple perspectives and
over multiple levels of analysis.
The latest research in the field suggests the need to go
beyond contrasting disease states with typical develop-
ment, instead comparing and contrasting the overlap-
ping phenomenology across conditions and asking such
questions as - What are the commonalities and differ-
ences in social cognition between autism and schizo-
phrenia [4]?; and What is the unique brain morphology
in children with autism associated with the presence of
the Fragile X mutation versus the brain as seen in those
with autistic behavior without an identifiable, associated
etiologic factor [5]? With the same rare mutations being
found in association with multiple phenotypes (e.g., glo-
bal developmental delay, in the case of copy number
variation of the 16p11 region), there is a critical need
for studies which cut across traditional phenotypic
boundaries linked to the most salient aspects of clinical
impairment. While traditional clinical phenotypes are
still of primary importance to clinicians, research find-
ings are pointing more towards the need to look beyond
these classical nosologies for alternate conceptualiza-
tions that may better map on to components of com-
mon, converging molecular pathways, or neural systems,
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any medium, provided the original work is properly cited.with notions about risk and susceptibility better reflect-
ing underlying pathogenetic mechanisms than classifica-
tions relying entirely on clinically-derived definitions. In
the area of intervention, targeted approaches to treat-
ment now require us to integrate across disciplines and
bioinformatics domains. So, for example, the recent dis-
covery of the ability of drugs used in the treatment of
p e d i a t r i cc a n c e r st ou n s i l e n c et h eU b e 3 ag e n ei na
mouse model of Angelman Syndrome and autism,
points to the urgent need for integration across disci-
plines and levels of inquiry [6].
These are truly exciting times for scientists working to
unravel the basis of neurodevelopmental disorders. The
tools we have at hand for both the discovery and disse-
mination of new knowledge are unprecedented. By
bringing together multiple perspectives on the patho-
genesis of neurodevelopmental disorders in this new
Journal, together with cutting-edge approaches for dis-
tributing this new knowledge throughout our scientific
community, the Journal of Neurodevelopmental Disor-
ders is poised to make an important contribution to our
field. We hope you share our enthusiasm for these
advances. We encourage you to consider submission of
your work to the Journal.
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